RecruitingNot ApplicableNCT06224205

Digital Detection of Dementia (D Cubed) Studies: D3


Sponsor

Indiana University

Enrollment

3,150 participants

Start Date

Nov 8, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The specific aim of the pragmatic trial is to evaluate the practical utility and effect of the PDM, the QDRS, and the combined approach (PDM + QDRS) in improving the annual rate of new documented ADRD diagnosis in primary care practices.


Eligibility

Min Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study uses electronic health records and digital tools to detect early signs of dementia in older adults who visit primary care clinics, before a formal diagnosis is made. You may be eligible if... - You are 65 years or older - You have visited your primary care provider at least once in the past year - You can communicate in English or Spanish - Your electronic health record data goes back at least three years You may NOT be eligible if... - You have already been diagnosed with Alzheimer's disease, dementia, or mild cognitive impairment - You have been prescribed memory medications like donepezil or memantine - You have a serious mental illness such as bipolar disorder or schizophrenia - You permanently live in a nursing facility Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPassive Digital Marker for screening for ADRD

Patients in the primary care clinics randomized to PDM+QDRS will have Electronic Health Record Data of their patients run through the PDM, a machine learning algorithm which can predict ADRD one year and three years prior to its onset. In addition, patients from these clinics will have their patients complete the QDRS, a validated patient reported outcome (PRO) tool. This combined approach will assess the value of early detection of ADRD and if the annual well visit can overcome the barriers related to early detection of ADRD.


Locations(1)

University of Miami School of Medicine

Boca Raton, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06224205


Related Trials